Company profile: Microsynbiotix
1.1 - Company Overview
Company description
- Provider of technology to eliminate excessive antibiotic use in farmed fish by engineering microalgae, leveraging advances in algal genomics and molecular biology to express inexpensive therapeutic proteins and vaccines of economic value.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Microsynbiotix
Evonetix
HQ: United Kingdom
Website
- Description: Provider of a benchtop platform that synthesizes, assembles, and error-corrects gene-length DNA on a silicon chip with unprecedented accuracy and scale using thermal control of DNA synthesis. Offers chip technology to synthesize thousands of oligonucleotide sequences simultaneously, binary assembly, and thermal error removal for rapid, precise gene synthesis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evonetix company profile →
Selecta Biosciences
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology focused on overcoming immunogenicity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Selecta Biosciences company profile →
BioLamina
HQ: Sweden
Website
- Description: Provider of cell culture matrices based on human recombinant laminins for primary cells and stem cell applications. Products include Biolaminin 521 LN and 521 MX for chemically defined, feeder-free self-renewal of human ES/iPS cells (LN: animal origin-free; MX: animal origin-free to the secondary level); 521 CTG for clinical studies and feeder-free culture of PSCs, MSCs, and progenitor cells; 111/121 LN as general attachment proteins; and 211 LN for tissue-specific cell growth and differentiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLamina company profile →
Castle Biosciences
HQ: United States
Website
- Description: Provider of molecular and genomic diagnostic tests for cancer, including DecisionDx-Melanoma for risk of recurrence, metastasis and sentinel lymph node positivity in cutaneous melanoma; DecisionDx-SCC for nodal or distant metastasis risk in SCC; TissueCypher to predict progression to esophageal cancer in Barrett’s esophagus; DecisionDx-UM for metastatic risk in uveal melanoma; and IDgenetix to guide personalized mental health medication selection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Castle Biosciences company profile →
Bioline
HQ: United Kingdom
Website
- Description: Provider of fast, easy-to-use, guaranteed-to-work products developed by scientists to help customers focus on their scientific goals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioline company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Microsynbiotix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Microsynbiotix
2.2 - Growth funds investing in similar companies to Microsynbiotix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Microsynbiotix
4.2 - Public trading comparable groups for Microsynbiotix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →